0001746726-21-000001.txt : 20210104 0001746726-21-000001.hdr.sgml : 20210104 20210104152354 ACCESSION NUMBER: 0001746726-21-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210104 DATE AS OF CHANGE: 20210104 EFFECTIVENESS DATE: 20210104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Virion Therapeutics, LLC CENTRAL INDEX KEY: 0001746726 IRS NUMBER: 274966374 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-352490 FILM NUMBER: 21501606 BUSINESS ADDRESS: STREET 1: 7 CREEK BEND COURT CITY: NEWARK STATE: DE ZIP: 19711 BUSINESS PHONE: 800-841-9303 MAIL ADDRESS: STREET 1: 7 CREEK BEND COURT CITY: NEWARK STATE: DE ZIP: 19711 D/A 1 primary_doc.xml X0708 D/A LIVE 0001746726 Virion Therapeutics, LLC 7 CREEK BEND COURT NEWARK DE DELAWARE 19711 800-841-9303 DELAWARE None None Limited Liability Company true 2018 Bernard Rudnick 7 Creek Bend Court Newark DE DELAWARE 19711 Executive Officer Director Andrew Luber 7 Creek Bend Court Newark DE DELAWARE 19711 Executive Officer Director Biotechnology No Revenues 06b true 0001746726-20-000007 2019-10-28 true true false 25000 6000000 1125000 4875000 false 22 0 0 0 true false Virion Therapeutics, LLC /s/Andrew Luber Andrew Luber CEO 2021-01-04